China Biotech Services Holdings Limited disclosed that Executive Director He Xun has tendered his resignation, effective 1 May 2026, citing other business commitments requiring greater attention.
The company confirmed that He Xun has no disagreements with the board, and no matters need to be brought to the attention of The Stock Exchange of Hong Kong Limited or shareholders in relation to his departure. The board expressed sincere gratitude for He Xun’s contributions during his tenure.
As of the announcement date (30 April 2026), the board comprises four executive directors—Liu Xiaolin (Chairman), He Xun, Huang Song and Yin Ye—and three independent non-executive directors—Yan Guoxiang, Guo Yuantao and Zhang Xiao.
The notice will remain available on the HKEX website for at least seven days and on the company’s website at www.cbshhk.com.